Biolytica has developed Biolytica NEXUS, an AI-driven health data platform that aggregates, visualizes and analyzes genomics, blood and epigenetic biomarkers, microbiome data, wearable-device and lifestyle information. The platform is sold to healthcare professionals—preventive medicine institutions, longevity centres, personalised wellness clinics—and insurance companies, while Biolytica also offers B2C concierge health optimization and longevity programs delivered by its team of longevity experts. Biolytica NEXUS traces conceptual origins to 2016, was in stealth from October 2021, and made its initial launch this year, already reporting promising metrics and results. The company uses AI to generate personalized health journeys, improve predictions, and support preventive, human-focused care aimed at extending healthspan. With the recent €5.34 million financing from Maximon Longevity Co-Investment Fund, Biolytica plans to expand R&D, scale services to a wider client base and collaborate with leading experts and clinics. The startup is positioning itself in the growing longevity and preventive-health market to become a leading data platform for personalized health and prevention.

Total raised

$6M

Funding rounds

1

Latest round

Equity

Latest activity

May 2023